; (D) recommendations for developing integrated care settings inclusive of overdose prevention sites and incorporating overdose prevention sites into referral networks; and (E) recommended approaches to overdose prevention services that may serve as effective strategies for recovery for people using fentanyl, fentanyl-related substances, other synthetic opioids, and new emerging drugs of abuse (including harmful adulterants of fentanyl, such as xylazine). 307. Prisons and substance use disorder treatment (a) Prisons and medication-Assisted treatment (1) In general The Director of the Bureau of Prisons, in collaboration with the Director of the Office of National Drug Control Policy, shall establish a program to offer— (A) all drugs that are approved by the Food and Drug Administration for treatment of a substance use disorder; (B) counseling and other psychosocial treatments for the treatment of substance use disorder; and (C) evidence-based withdrawal management services to individuals in the custody of the Bureau of Prisons to provide a comprehensive treatment approach substance use disorders. (2) Authorization of appropriations There are authorized to be appropriated to carry out this subsection such sums as are necessary. (b) Residential substance abuse treatment for State prisoners Section 1904(d) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 ( 34 U.S.C. 10424(d) ) is amended— (1) by striking means and inserting the following: (1) means ; (2) by striking the period at the end and inserting ; and ; and (3) by adding at the end the following: (2) includes any such course of comprehensive individual and group substance abuse treatment services using medication-assisted treatment for opioid use disorder (including the use of any drug approved or licensed by the Food and Drug Administration for such treatment). .